Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Consolidated Net Income/Loss of $-6.05M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.05M |
|
-- |
|
-- |
|
$6.07M |
|
$-6.07M |
|
$0.03M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
|
Consolidated Net Income/Loss |
$-6.05M |
$-6.05M |
|
$-6.07M |
|
$-6.07M |
|
49.85M |
|
49.85M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$10.82M |
|
-- |
|
$0.82M |
|
$11.63M |
|
$12.08M |
|
-- |
|
$0.02M |
|
$12.09M |
|
$-0.46M |
|
$-0.46M |
|
$-0.46M |
|
68.00M |
|
| Cash Flow Statement Financials | |
$-13.21M |
|
-- |
|
$10.09M |
|
$13.48M |
|
$10.36M |
|
$-3.11M |
|
$1.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.90 |
|
-- |
|
-- |
|
-- |
|
-0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
1318.43% |
|
1318.45% |
|
-52.03% |
|
1318.45% |
|
$-0.01 |
|
$-0.26 |
|
$-0.26 |
|